Theriva Biologics, Inc.

8-K Regulation FD disclosure; Other events Jul 7, 2026 8-K Regulation FD disclosure; Other events Jun 11, 2026 8-K Other events Jun 5, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Regulation FD disclosure; Other events Apr 17, 2026 8-K Other events Apr 9, 2026 8-K Regulation FD disclosure; Other events Mar 23, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Entered a material agreement; Regulation FD disclosure Feb 18, 2026 8-K Other events Feb 12, 2026 8-K Other events Jan 12, 2026 8-K Regulation FD disclosure; Other events Dec 29, 2025 8-K Other events Dec 15, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Other events Oct 29, 2025 8-K Other events Oct 24, 2025 8-K Other events Oct 20, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Oct 17, 2025 8-K Regulation FD disclosure; Other events Oct 14, 2025 8-K Other events Oct 8, 2025 8-K Regulation FD disclosure; Other events Oct 6, 2025 8-K Exit or disposal costs Oct 2, 2025 8-K Director or officer change; Shareholder vote results Sep 4, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Other events Jun 25, 2025 8-K Other events Jun 20, 2025 8-K Regulation FD disclosure; Other events Jun 2, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Entered a material agreement; Other events May 8, 2025 8-K Regulation FD disclosure; Other events May 7, 2025 8-K Regulation FD disclosure; Other events Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Results of operations (earnings release) Mar 6, 2025 8-K Regulation FD disclosure; Other events Dec 5, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024